- US stocks wavered on Tuesday as momentum from Monday’s rally extended the shift from expensive growth stocks to small-cap and cyclical picks.
- The tech-heavy Nasdaq composite sank, while the Dow Jones industrial average and the small-cap-focused Russell 2000 gained.
- While Pfizer and BioNTech’sMonday vaccine update bolstered investors’ risk appetites, soaring COVID-19 case counts offset some optimism.
- Oil prices continued to climb as vaccine hopes improved demand outlooks. West Texas Intermediate crude gained as much as 2.9%, to $US41.46 per barrel.
- Watch major indexes update live here.
US equities fluctuated on Tuesday investors continued to pivot away from growth stocks and bolstered bets on near-term economic recovery.
Pfizer and BioNTech’s encouraging vaccine update, which fuelled a massive stock surge on Monday, continued to drive a shift out of expensive tech stocks and into plays more likely to outperform in an economic reopening.
The tech-heavy Nasdaq composite slumped, while Dow Jones industrial average and the small-cap-focused Russell 2000 gained. Popular stay-at-home plays including Netflix,Zoom, and Amazon continued to fall as investors bet on near-term vaccine distribution.
Here’s where US indexes stood at the 4 p.m. ET close on Tuesday:
- S&P 500:3,545.45, down 0.14%
- Dow Jones industrial average: 29,320.59, up 0.9% (262 points)
- Nasdaq composite:11,553.86, down 1.37%
“With a viable vaccine apparently on the horizon, it may be time to take a second look at your portfolio,” said Lindsey Bell, the chief investment strategist for Ally Invest. “Stocks that could benefit from a return to normal life â€” or the ‘reopening trade’ â€” could be worth watching over the coming weeks.”
The Dow and the S&P 500 leaped to record intraday highs on Monday. Pfizer’s update lifted investors’ risk appetites and kicked off the week’s rotation to cyclical names. Reopening trades such as airlines, cruises, and hotels gained. Gold tumbled the most in three months as investors ditched safe-haven assets.
Pfizer and BioNTech announced Monday that their experimental coronavirus vaccine was found to be more than 90% effective at preventing COVID-19 in a late-stage trial. The companies now plan to apply for emergency use authorization with the US Food and Drug Administration to expedite the rollout of their vaccine. The announcement suggests a breakthrough in the race to find a viable vaccine and spurred hope on Wall Street that the pandemic might be contained sooner than previously expected.
Whether it could arrive soon enough to avoid additional economic damage is a different story. The US reached 10 million COVID-19 cases on Monday as infection rates spiked across the country. The Federal Reserve said in a Monday report that an inability to contain the outbreak could tank asset prices across risk markets.
Goldman Sachs combed through hundreds of earnings transcripts to arrive at the 4 themes S&P 500 companies embraced this quarter â€” and shared the dozens of stocks set to benefit from these thematic trends
Beyond facing pressure from the broad market rotation, Amazon sank after the European Union unveiled formal antitrust charges against the e-commerce titan. The EU’s top antitrust official alleged Amazon illegally abused its dominant position in Germany and France.
Beyond Meat cratered after the firm reported an unexpected third-quarter loss and missed revenue estimates. Shares hit their lowest since May as Wall Street scrutinised the worse-than-expected results.
Alibaba tumbled as regulatory concerns overshadowed massive sales for the company’s Singles Day event. The Wall Street Journal reported Tuesday that Chinese regulators released a new draft of antimonopoly rules that could drag on online platforms like Alibaba.
Peloton erased early gains and traded higher after the company inked a multi-year deal with Beyonce. The artist will produce several exclusive workout programs themed around homecoming, the annual fall celebration for students at historically Black colleges and universities.
Spot gold climbed as much as 1.5%, to an intraday high of $US1,890.53 per ounce. The US dollar fell slightly, and Treasury yields ticked higher.
Bitcoin traded just below $US15,300 after failing to break above $US16,000 in its prolonged rally. The cryptocurrency’s recent momentum has mostly stalled since it traded above $US15,000.
Oil prices continued to climb, retaking their $US40-per-barrel support level. West Texas Intermediate crude gained as much as 2.9%, to $US41.46 per barrel. Brent crude, oil’s international benchmark, jumped 3%, to $US43.66 per barrel, at intraday highs.
Now read more markets coverage from Markets Insider and Business Insider:
Business Insider Emails & Alerts
Site highlights each day to your inbox.